Key Highlights
- Barclays upgraded XOM’s price target from $145 to $163 while maintaining its Overweight rating, pointing to elevated 2026 oil price projections linked to the Iran situation.
- Piper Sandler took a more aggressive stance, increasing its target from $145 to $186 with an Overweight rating, while also raising mid-cycle WTI forecasts by $5.00 per barrel.
- Shares of XOM began Monday trading at $156.29, representing a 1.8% gain and hovering close to the 52-week peak of $159.60.
- Several institutional players expanded their XOM holdings during Q3, including Focus Partners Wealth, which increased its position by 13.3%.
- The company’s Q4 earnings surpassed expectations with EPS of $1.71 compared to the consensus estimate of $1.63, while revenue reached $80.04 billion.
Shares of Exxon Mobil (XOM) began Monday’s session at $156.29, climbing 1.8% and nearing the 52-week peak of $159.60. The upward momentum followed price target revisions from two prominent Wall Street institutions last week.
On March 13, Barclays elevated its XOM price objective to $163 from the previous $145 target while keeping its Overweight designation. The investment bank indicated it has revised upward its 2026 oil price projections due to the Iran conflict, noting that the market appears to be undervaluing the cash flow advantages for exploration and production companies.
While Barclays recognized that the current oil price surge “unlikely to last for long,” analysts contend that investors are overlooking the complete cash flow impact — particularly the sustainable enhancement it could provide to the sector’s capacity for increased cash distributions even after the conflict subsides.
Piper Sandler delivered an even more optimistic assessment on March 12, elevating its XOM target to $186 from $145 while maintaining an Overweight stance. The firm increased its mid-cycle WTI price projection by $5.00 per barrel, also attributing the change to enduring consequences of the Iran situation.
According to Piper Sandler’s commodity analysts, crude oil supply fundamentals for 2026 are expected to tighten by approximately 2.0 million barrels daily compared to earlier projections. The firm additionally noted that persistent risk premiums and worldwide resource constraints will elevate threshold requirements for future energy sector investments.
Institutional Ownership Expands
Focus Partners Wealth expanded its XOM position by 13.3% during Q3, acquiring an additional 284,171 shares to reach a total holding of 2,420,775. The stake was valued at approximately $273 million by the quarter’s conclusion.
Numerous other institutional players also increased their positions during the same period. Destination Wealth Management expanded its holdings by 94.6%, while Elevation Point Wealth Partners grew its stake by 30.4%. EagleClaw Capital increased its position by 38.8%. Collectively, institutional investors and hedge funds control 61.8% of XOM shares.
However, not all insiders are accumulating — company vice president Darrin L. Talley divested 5,000 shares in early February at an average price of $139.75, reducing his holdings by 17.49%.
Financial Performance and Shareholder Returns
XOM delivered Q4 earnings per share of $1.71, surpassing the analyst consensus of $1.63 by $0.08. Revenue totaled $80.04 billion, exceeding the anticipated $77.98 billion, despite representing a 1.3% year-over-year decline.
The corporation distributed a quarterly dividend of $1.03 per share on March 10, equating to an annualized yield of 2.6%. The current dividend payout ratio stands at 61.58%.
XOM’s 50-day moving average sits at $141.99, while the 200-day moving average is $124.76. The stock maintains a market capitalization of $651.20 billion with a price-to-earnings ratio of 23.36.
One potential headwind for the oil rally: President Trump has indicated he may utilize the Strategic Petroleum Reserve to suppress fuel prices, a strategy that could limit crude oil’s upside potential going forward.
Wall Street analysts maintain an average “Hold” rating on XOM, with a consensus price target of $146.00. The stock receives nine Buy ratings, eight Hold ratings, and one Sell rating.





